German Rheumatology Research Center
@drfzberlin.bsky.social
Eicke Latz Highly Cited Researcher
Our Scientific Director, Prof. Dr. Eicke Latz, is one of the world's most influential researchers of 2025, as the recently published list of “Highly Cited Researchers” by Clarivate shows.
www.drfz.de/neuigkeiten/...
Our Scientific Director, Prof. Dr. Eicke Latz, is one of the world's most influential researchers of 2025, as the recently published list of “Highly Cited Researchers” by Clarivate shows.
www.drfz.de/neuigkeiten/...
Eicke Latz unter den weltweit meistzitierten Forschenden - DRFZ
Eicke Latz vom Deutschen Rheuma-Forschungszentrum Berlin, ein Leibniz-Institut ist Highly Cited Researcher 2025
www.drfz.de
November 12, 2025 at 1:53 PM
Eicke Latz Highly Cited Researcher
Our Scientific Director, Prof. Dr. Eicke Latz, is one of the world's most influential researchers of 2025, as the recently published list of “Highly Cited Researchers” by Clarivate shows.
www.drfz.de/neuigkeiten/...
Our Scientific Director, Prof. Dr. Eicke Latz, is one of the world's most influential researchers of 2025, as the recently published list of “Highly Cited Researchers” by Clarivate shows.
www.drfz.de/neuigkeiten/...
Epigenetic Imprints of Immune Memory across the Human Body: Andreas Radbruch from DRFZ and colleagues discovered how immune cells are epigenetically imprinted to provide protection against repeated infections by pathogens - published in the journal Immunity & Inflammation. bit.ly/3IQnUNW
Wie Epigenetik das Immungedächtnis im gesamten menschlichen Körper prägt - DRFZ
Jun Dong aus der Gruppe von Andreas Radbruch vom DRFZ zeigt wie Epigenetik das Immungedächtnis im gesamten menschlichen Körper prägt
bit.ly
October 2, 2025 at 6:18 AM
Epigenetic Imprints of Immune Memory across the Human Body: Andreas Radbruch from DRFZ and colleagues discovered how immune cells are epigenetically imprinted to provide protection against repeated infections by pathogens - published in the journal Immunity & Inflammation. bit.ly/3IQnUNW
Reposted by German Rheumatology Research Center
#Rheuma wird bei #Frauen oft später diagnostiziert als bei Männern – aber keineswegs, weil sie seltener betroffen sind. Auf dem Deutschen #Rheumatologiekongress diskutiert eine Expertin vom @drfzberlin.bsky.social geschlechtsspezifische Unterschiede.
September 17, 2025 at 6:30 AM
#Rheuma wird bei #Frauen oft später diagnostiziert als bei Männern – aber keineswegs, weil sie seltener betroffen sind. Auf dem Deutschen #Rheumatologiekongress diskutiert eine Expertin vom @drfzberlin.bsky.social geschlechtsspezifische Unterschiede.
Dr. Lisa Budzinski from DRFZ was awarded the Klaus Goerttler Prize at the 35th Conference of the DGfZ. This prize recognizes the exceptional research work of the biotechnologist, who completed her PhD this year at the German Rheumatology Research Center Berlin, a Leibniz Institute. bit.ly/42jhn4M
Lisa Budzinski honored with Klaus Goerttler Prize Prize - DRFZ
Award by the German Society of Cytometry Dr. Lisa Budzinski was awarded the Klaus Goerttler Prize at the 35th Conference of the German Society for…
bit.ly
September 11, 2025 at 7:20 AM
Dr. Lisa Budzinski from DRFZ was awarded the Klaus Goerttler Prize at the 35th Conference of the DGfZ. This prize recognizes the exceptional research work of the biotechnologist, who completed her PhD this year at the German Rheumatology Research Center Berlin, a Leibniz Institute. bit.ly/42jhn4M
On September 9, 2025, PD Dr. rer. nat. Mir-Farzin Mashreghi gave his inaugural lecture “From Immune Response to Long-Term Immunity". On June 16, 2025, Mir-Farzin Mashreghi habilitated at Charité – Universitätsmedizin Berlin, thereby qualifying him to teach experimental pediatrics.
bit.ly/4p7JrBY
bit.ly/4p7JrBY
September 10, 2025 at 11:21 AM
On September 9, 2025, PD Dr. rer. nat. Mir-Farzin Mashreghi gave his inaugural lecture “From Immune Response to Long-Term Immunity". On June 16, 2025, Mir-Farzin Mashreghi habilitated at Charité – Universitätsmedizin Berlin, thereby qualifying him to teach experimental pediatrics.
bit.ly/4p7JrBY
bit.ly/4p7JrBY
NLRP3 as a driver of inflammation
Eicke Latz from DRFZ and colleagues have published a review about NLRP3 in the journal Nature Immunology. The article summarizes the current state of knowledge about this key molecule driving atherosclerosis, Alzheimer's disease, and gout.
bit.ly/3JyPFdO
Eicke Latz from DRFZ and colleagues have published a review about NLRP3 in the journal Nature Immunology. The article summarizes the current state of knowledge about this key molecule driving atherosclerosis, Alzheimer's disease, and gout.
bit.ly/3JyPFdO
August 26, 2025 at 8:19 AM
NLRP3 as a driver of inflammation
Eicke Latz from DRFZ and colleagues have published a review about NLRP3 in the journal Nature Immunology. The article summarizes the current state of knowledge about this key molecule driving atherosclerosis, Alzheimer's disease, and gout.
bit.ly/3JyPFdO
Eicke Latz from DRFZ and colleagues have published a review about NLRP3 in the journal Nature Immunology. The article summarizes the current state of knowledge about this key molecule driving atherosclerosis, Alzheimer's disease, and gout.
bit.ly/3JyPFdO
Our colleagues from the DRFZ, together with the @mpiib-berlin.mpg.de, delighted 1686 guests with the fascinating world of research until late into the Long Night of Science on June 28, 2025.
Thanx to all making the #lndw2025 an unforgettable event!
www.drfz.de/en/neuigkeit...
Thanx to all making the #lndw2025 an unforgettable event!
www.drfz.de/en/neuigkeit...
June 30, 2025 at 3:59 PM
Our colleagues from the DRFZ, together with the @mpiib-berlin.mpg.de, delighted 1686 guests with the fascinating world of research until late into the Long Night of Science on June 28, 2025.
Thanx to all making the #lndw2025 an unforgettable event!
www.drfz.de/en/neuigkeit...
Thanx to all making the #lndw2025 an unforgettable event!
www.drfz.de/en/neuigkeit...
Eicke Latz is a new BBAW member
Prof. Dr. Eicke Latz, Scientific Director of the German Rheumatology Research Center, a Leibniz-Institute, has been welcomed as a full member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW).
More: www.drfz.de/en/neuigkeit...
Prof. Dr. Eicke Latz, Scientific Director of the German Rheumatology Research Center, a Leibniz-Institute, has been welcomed as a full member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW).
More: www.drfz.de/en/neuigkeit...
June 19, 2025 at 8:53 AM
Eicke Latz is a new BBAW member
Prof. Dr. Eicke Latz, Scientific Director of the German Rheumatology Research Center, a Leibniz-Institute, has been welcomed as a full member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW).
More: www.drfz.de/en/neuigkeit...
Prof. Dr. Eicke Latz, Scientific Director of the German Rheumatology Research Center, a Leibniz-Institute, has been welcomed as a full member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW).
More: www.drfz.de/en/neuigkeit...
Reposted by German Rheumatology Research Center
Im Rahmen der Gremiensitzungen im Vorfeld des Leibniztages wurden drei neue Mitglieder in die Akademie aufgenommen: der Neurobiologe Frank Bradke (@dzne.science), der Mediziner Eike Latz (@drfzberlin.bsky.social) und der Lebensmitteltechnologe Alexander Mathys (@ethz.ch). Herzlich willkommen!
June 16, 2025 at 8:02 AM
Im Rahmen der Gremiensitzungen im Vorfeld des Leibniztages wurden drei neue Mitglieder in die Akademie aufgenommen: der Neurobiologe Frank Bradke (@dzne.science), der Mediziner Eike Latz (@drfzberlin.bsky.social) und der Lebensmitteltechnologe Alexander Mathys (@ethz.ch). Herzlich willkommen!
Six relay teams from the DRFZ took part in the 5x5 km Team Relay of Berliner Wasserbetriebe on June 5, 2025.
More plus gallery: www.drfz.de/en/neuigkeit...
More plus gallery: www.drfz.de/en/neuigkeit...
June 6, 2025 at 11:29 AM
Six relay teams from the DRFZ took part in the 5x5 km Team Relay of Berliner Wasserbetriebe on June 5, 2025.
More plus gallery: www.drfz.de/en/neuigkeit...
More plus gallery: www.drfz.de/en/neuigkeit...
Andreas Radbruch and colleagues from the #DRFZ find a mechanism how surface CD69 negative memory T cells are retained in the bone marrow.
Read more: www.drfz.de/en/neuigkeit...
Read more: www.drfz.de/en/neuigkeit...
June 5, 2025 at 9:36 AM
Andreas Radbruch and colleagues from the #DRFZ find a mechanism how surface CD69 negative memory T cells are retained in the bone marrow.
Read more: www.drfz.de/en/neuigkeit...
Read more: www.drfz.de/en/neuigkeit...
Our new movie about the DRFZ is now on YouTube
A lot is new at the DRFZ. After the change of institute management, the DRFZ image was refreshed and now the new short film about the DRFZ's research tasks is ready.
youtu.be/uBchCSyo-Do
A lot is new at the DRFZ. After the change of institute management, the DRFZ image was refreshed and now the new short film about the DRFZ's research tasks is ready.
youtu.be/uBchCSyo-Do
Film about DRFZ
YouTube video by Deutsches Rheuma-Forschungszentrum Berlin
youtu.be
June 4, 2025 at 9:36 AM
Our new movie about the DRFZ is now on YouTube
A lot is new at the DRFZ. After the change of institute management, the DRFZ image was refreshed and now the new short film about the DRFZ's research tasks is ready.
youtu.be/uBchCSyo-Do
A lot is new at the DRFZ. After the change of institute management, the DRFZ image was refreshed and now the new short film about the DRFZ's research tasks is ready.
youtu.be/uBchCSyo-Do
Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research
The DRFZ is part of the new Cluster of Excellence
Read more at our website: www.drfz.de/en/neuigkeit...
The DRFZ is part of the new Cluster of Excellence
Read more at our website: www.drfz.de/en/neuigkeit...
Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ
The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.
www.drfz.de
May 22, 2025 at 4:05 PM
Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research
The DRFZ is part of the new Cluster of Excellence
Read more at our website: www.drfz.de/en/neuigkeit...
The DRFZ is part of the new Cluster of Excellence
Read more at our website: www.drfz.de/en/neuigkeit...
We like to invite you to join the 35th Annual Meeting of the German Society for Cytometry this year in Dresden on September 9-12.
Early bird registration & abstract submission until 31st of May!
For more information please have a look at the meeting website: dgfz.org/2025/
Early bird registration & abstract submission until 31st of May!
For more information please have a look at the meeting website: dgfz.org/2025/
May 13, 2025 at 1:54 PM
We like to invite you to join the 35th Annual Meeting of the German Society for Cytometry this year in Dresden on September 9-12.
Early bird registration & abstract submission until 31st of May!
For more information please have a look at the meeting website: dgfz.org/2025/
Early bird registration & abstract submission until 31st of May!
For more information please have a look at the meeting website: dgfz.org/2025/
Book a Scientist – am 3. Juni 2025
Das „Speed-Dating mit der Wissenschaft“ bietet Wissenschaftsinteressierten die Gelegenheit, in individuellen Online-Gesprächen die Forschung von Wissenschaftler:innen der Leibniz-Gemeinschaft kennenzulernen - mit dabei Johannes Groffmann vom DRFZ. bit.ly/3EYiizd
Das „Speed-Dating mit der Wissenschaft“ bietet Wissenschaftsinteressierten die Gelegenheit, in individuellen Online-Gesprächen die Forschung von Wissenschaftler:innen der Leibniz-Gemeinschaft kennenzulernen - mit dabei Johannes Groffmann vom DRFZ. bit.ly/3EYiizd
May 6, 2025 at 11:08 AM
Book a Scientist – am 3. Juni 2025
Das „Speed-Dating mit der Wissenschaft“ bietet Wissenschaftsinteressierten die Gelegenheit, in individuellen Online-Gesprächen die Forschung von Wissenschaftler:innen der Leibniz-Gemeinschaft kennenzulernen - mit dabei Johannes Groffmann vom DRFZ. bit.ly/3EYiizd
Das „Speed-Dating mit der Wissenschaft“ bietet Wissenschaftsinteressierten die Gelegenheit, in individuellen Online-Gesprächen die Forschung von Wissenschaftler:innen der Leibniz-Gemeinschaft kennenzulernen - mit dabei Johannes Groffmann vom DRFZ. bit.ly/3EYiizd
Der Kartenverkauf hat begonnen!
Die Karten kosten in diesem Jahr nur 5 EUR!
Feiern Sie mit uns das 25 jährige Jubiläum der Langen Nacht der Wissenschaften am 28. Juni 2025 ab 17:00 Uhr bis Mitternacht.
Das Programm am DRFZ:
www.drfz.de/veranstaltun...
Die Karten kosten in diesem Jahr nur 5 EUR!
Feiern Sie mit uns das 25 jährige Jubiläum der Langen Nacht der Wissenschaften am 28. Juni 2025 ab 17:00 Uhr bis Mitternacht.
Das Programm am DRFZ:
www.drfz.de/veranstaltun...
Lange Nacht der Wissenschaften 2025 - DRFZ
Jährlich im Juni laden das DRFZ und über 50 weitere Berliner Institutionen zur Langen Nacht der Wissenschaften ein.
www.drfz.de
April 8, 2025 at 11:18 AM
Der Kartenverkauf hat begonnen!
Die Karten kosten in diesem Jahr nur 5 EUR!
Feiern Sie mit uns das 25 jährige Jubiläum der Langen Nacht der Wissenschaften am 28. Juni 2025 ab 17:00 Uhr bis Mitternacht.
Das Programm am DRFZ:
www.drfz.de/veranstaltun...
Die Karten kosten in diesem Jahr nur 5 EUR!
Feiern Sie mit uns das 25 jährige Jubiläum der Langen Nacht der Wissenschaften am 28. Juni 2025 ab 17:00 Uhr bis Mitternacht.
Das Programm am DRFZ:
www.drfz.de/veranstaltun...
Andreas Radbruch, #DRFZ & #EFIS, welcomes the participants of the EFIS symposium "The Reaction to #SARS-CoV-2: an Immunological Retrospective" taking place in Berlin today.
www.efis.org/news/efis-sy...
www.efis.org/news/efis-sy...
April 4, 2025 at 9:21 AM
Andreas Radbruch, #DRFZ & #EFIS, welcomes the participants of the EFIS symposium "The Reaction to #SARS-CoV-2: an Immunological Retrospective" taking place in Berlin today.
www.efis.org/news/efis-sy...
www.efis.org/news/efis-sy...
Alexandra Damerau and Timo Gaber, DRFZ and Charité, have used an in-vitro 3D model to show that mechanical stress can attenuate inflammation-induced cartilage degradation in osteoarthritis. They also demonstrated the anti-inflammatory effect of JAK inhibitors.
More: bit.ly/3DUuujU
More: bit.ly/3DUuujU
3D model for cartilage degradation - DRFZ
Alexandra Damerau and Dr. Timo Gaber, DRFZ and Charité, used an in-vitro 3D model to investigate mechanical influences on cartilage tissue.
bit.ly
March 26, 2025 at 2:31 PM
Alexandra Damerau and Timo Gaber, DRFZ and Charité, have used an in-vitro 3D model to show that mechanical stress can attenuate inflammation-induced cartilage degradation in osteoarthritis. They also demonstrated the anti-inflammatory effect of JAK inhibitors.
More: bit.ly/3DUuujU
More: bit.ly/3DUuujU
The local application of deferoxamine (DFO) significantly accelerates fracture healing, as a systematic review and meta-analysis of 21 studies compiled by Dr. Paula Hoff and Dr. Timo Gaber from DRFZ and Charité - Universitätsmedizin Berlin shows. More at our website: bit.ly/4l0eGwG
March 26, 2025 at 1:58 PM
The local application of deferoxamine (DFO) significantly accelerates fracture healing, as a systematic review and meta-analysis of 21 studies compiled by Dr. Paula Hoff and Dr. Timo Gaber from DRFZ and Charité - Universitätsmedizin Berlin shows. More at our website: bit.ly/4l0eGwG
Period blood for research? Ping Shen in an ARTE interview
“Are we wasting period blood?” Dr. Ping Shen from Pitzer Laboratory for Osteoarthritis Research at DRFZ even collects menstrual blood for her research.
Link to video with interview: bit.ly/4hJN8c8
Link to News at DRFZ website: bit.ly/4hSqCOv
“Are we wasting period blood?” Dr. Ping Shen from Pitzer Laboratory for Osteoarthritis Research at DRFZ even collects menstrual blood for her research.
Link to video with interview: bit.ly/4hJN8c8
Link to News at DRFZ website: bit.ly/4hSqCOv
March 26, 2025 at 12:46 PM
Period blood for research? Ping Shen in an ARTE interview
“Are we wasting period blood?” Dr. Ping Shen from Pitzer Laboratory for Osteoarthritis Research at DRFZ even collects menstrual blood for her research.
Link to video with interview: bit.ly/4hJN8c8
Link to News at DRFZ website: bit.ly/4hSqCOv
“Are we wasting period blood?” Dr. Ping Shen from Pitzer Laboratory for Osteoarthritis Research at DRFZ even collects menstrual blood for her research.
Link to video with interview: bit.ly/4hJN8c8
Link to News at DRFZ website: bit.ly/4hSqCOv
Reposted by German Rheumatology Research Center
Join EFIS on 4 April for an encounter dedicated to exploring - from an immunological standpoint - the unresolved issues and misconceptions of COVID-19 vaccination five years after the WHO declaration of the pandemic.
Program:
www.efis.org/.../Reaction....
Register:
www.efis.org/events/efis-...
Program:
www.efis.org/.../Reaction....
Register:
www.efis.org/events/efis-...
March 20, 2025 at 10:41 AM
Join EFIS on 4 April for an encounter dedicated to exploring - from an immunological standpoint - the unresolved issues and misconceptions of COVID-19 vaccination five years after the WHO declaration of the pandemic.
Program:
www.efis.org/.../Reaction....
Register:
www.efis.org/events/efis-...
Program:
www.efis.org/.../Reaction....
Register:
www.efis.org/events/efis-...
Reposted by German Rheumatology Research Center
How does SARS-CoV-2 lead to the multisystem inflammatory syndrome in children, a rare, potentially fatal condition?
www.nature.com/articles/s41...
High levels of TGFβ interfere with the child's response to control Epstein Barr virus, leading to its reactivation and severe inflammation @nature.com
www.nature.com/articles/s41...
High levels of TGFβ interfere with the child's response to control Epstein Barr virus, leading to its reactivation and severe inflammation @nature.com
TGFβ links EBV to multisystem inflammatory syndrome in children - Nature
Multisystem inflammatory syndrome following SARS-CoV-2 infection results from increased serum levels of TGFβ, which impairs the reactivation of virus-specific T cells.
www.nature.com
March 12, 2025 at 4:39 PM
How does SARS-CoV-2 lead to the multisystem inflammatory syndrome in children, a rare, potentially fatal condition?
www.nature.com/articles/s41...
High levels of TGFβ interfere with the child's response to control Epstein Barr virus, leading to its reactivation and severe inflammation @nature.com
www.nature.com/articles/s41...
High levels of TGFβ interfere with the child's response to control Epstein Barr virus, leading to its reactivation and severe inflammation @nature.com
Exiting publication in Nature by DRFZ researchers: Congratulations!
Original publication: bit.ly/3Fn63Mt
News DRFZ: bit.ly/4kJ1AUq
Original publication: bit.ly/3Fn63Mt
News DRFZ: bit.ly/4kJ1AUq
Our latest study in @nature.com reveals how #TGFβ drives Epstein-Barr Virus (#EBV) reactivation in multisystem inflammatory syndrome in #children (#MISC, #PIMS) following #COVID19.
@drfzberlin.bsky.social @mashreghilab.bsky.social
🔗 Read here:https://www.nature.com/articles/s41586-025-08697-6
@drfzberlin.bsky.social @mashreghilab.bsky.social
🔗 Read here:https://www.nature.com/articles/s41586-025-08697-6
Nature
Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest ...
nature.com
March 12, 2025 at 4:28 PM
Exiting publication in Nature by DRFZ researchers: Congratulations!
Original publication: bit.ly/3Fn63Mt
News DRFZ: bit.ly/4kJ1AUq
Original publication: bit.ly/3Fn63Mt
News DRFZ: bit.ly/4kJ1AUq
Prof. Dr. Thomas Krieg is the new President of the Board of Trustees of the DRFZ, succeeding Prof. Dr. Elisabeth Märker-Hermann. Dr. med. Julia Rautenstrauch is elected Vice President of the Board of Trustees. www.drfz.de/en/neuigkeit...
March 10, 2025 at 12:19 PM
Prof. Dr. Thomas Krieg is the new President of the Board of Trustees of the DRFZ, succeeding Prof. Dr. Elisabeth Märker-Hermann. Dr. med. Julia Rautenstrauch is elected Vice President of the Board of Trustees. www.drfz.de/en/neuigkeit...
The DRFZ has restructured its research areas and now comprises four areas. Two new program areas have been formed from the previously largest program area Pathophysiology of Rheumatic Inflammation: Learn more: www.drfz.de/en/research-...
March 7, 2025 at 11:42 AM
The DRFZ has restructured its research areas and now comprises four areas. Two new program areas have been formed from the previously largest program area Pathophysiology of Rheumatic Inflammation: Learn more: www.drfz.de/en/research-...